Abstract
BackgroundIntratumoral delivery of immunotherapeutics represents a compelling solution to directly address local barriers to tumor immunity. However, we have previously shown that off-target delivery is a substantial problem during intratumoral...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have